Vincerx Pharma, Inc.

VINC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$30-$40-$65-$39
Dep. & Amort.$1$1$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$3$4$10$23
Change in WC-$0-$4-$1$6
Other Non-Cash-$0-$1-$4-$23
Operating Cash Flow-$26-$40-$60-$33
Investing Activities
PP&E Inv.$0$0$0-$5
Net Acquisitions$0$0$0$0
Inv. Purchases-$11-$12-$43$0
Inv. Sales/Matur.$12$53$2$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$42-$41-$5
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$18$0$0$47
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$41
Financing Cash Flow$18$0$0$88
Forex Effect$0-$0$0-$0
Net Chg. in Cash-$8$1-$100$50
Supplemental Information
Beg. Cash$13$12$112$62
End Cash$5$13$12$112
Free Cash Flow-$26-$40-$60-$39